FDA
-
-
-
-
-
-
-
Know Labs to Attend the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
-
-
-
-
-
-
-
Know Labs, Inc (KNW) Responds to NYSE Commencement of Proceedings to Delist
-
-
-
-
-
-
-
Know Labs Publishes Clinical Results in Leading Diabetes Journal
-
-
-
-
-
-
-
Benchmark Starts Know Labs (KNW) at Speculative Buy
-
-
-
-
-
-
-
Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results
-
-
-
-
-
-
-
Know Labs, Inc (KNW) Demonstrates Improved Accuracy of Machine Learning Model for Non-Invasive Glucose Monitor
-
-
-
-
-
-
-
Know Labs, Inc. Reports Second Quarter FY2023 Results
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

